DK1337535T3 - Benzodiazepinderivater som GABA A-receptormodulatorer - Google Patents

Benzodiazepinderivater som GABA A-receptormodulatorer

Info

Publication number
DK1337535T3
DK1337535T3 DK01996541T DK01996541T DK1337535T3 DK 1337535 T3 DK1337535 T3 DK 1337535T3 DK 01996541 T DK01996541 T DK 01996541T DK 01996541 T DK01996541 T DK 01996541T DK 1337535 T3 DK1337535 T3 DK 1337535T3
Authority
DK
Denmark
Prior art keywords
gaba
receptor modulators
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
DK01996541T
Other languages
Danish (da)
English (en)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1337535T3 publication Critical patent/DK1337535T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01996541T 2000-11-16 2001-11-08 Benzodiazepinderivater som GABA A-receptormodulatorer DK1337535T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16
PCT/EP2001/012887 WO2002040487A2 (en) 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
DK1337535T3 true DK1337535T3 (da) 2004-10-25

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996541T DK1337535T3 (da) 2000-11-16 2001-11-08 Benzodiazepinderivater som GABA A-receptormodulatorer

Country Status (40)

Country Link
US (1) US6743789B2 (enExample)
EP (1) EP1337535B1 (enExample)
JP (1) JP4088151B2 (enExample)
KR (1) KR100504300B1 (enExample)
CN (1) CN1191255C (enExample)
AR (1) AR031345A1 (enExample)
AT (1) ATE268776T1 (enExample)
AU (2) AU1700702A (enExample)
BG (1) BG107817A (enExample)
BR (1) BR0115393A (enExample)
CA (1) CA2427576C (enExample)
CZ (1) CZ295256B6 (enExample)
DE (1) DE60103776T2 (enExample)
DK (1) DK1337535T3 (enExample)
EC (1) ECSP034607A (enExample)
ES (1) ES2220831T3 (enExample)
GC (1) GC0000375A (enExample)
GT (1) GT200100230A (enExample)
HR (1) HRP20030360A2 (enExample)
HU (1) HUP0303281A3 (enExample)
IL (1) IL155813A0 (enExample)
JO (1) JO2359B1 (enExample)
MA (1) MA26962A1 (enExample)
MX (1) MXPA03004251A (enExample)
MY (1) MY141675A (enExample)
NO (1) NO324706B1 (enExample)
NZ (1) NZ525413A (enExample)
PA (1) PA8532401A1 (enExample)
PE (1) PE20020583A1 (enExample)
PL (1) PL362925A1 (enExample)
PT (1) PT1337535E (enExample)
RU (1) RU2278865C2 (enExample)
SI (1) SI1337535T1 (enExample)
SK (1) SK7232003A3 (enExample)
TR (1) TR200402073T4 (enExample)
TW (1) TWI239333B (enExample)
UY (1) UY27026A1 (enExample)
WO (1) WO2002040487A2 (enExample)
YU (1) YU35603A (enExample)
ZA (1) ZA200303435B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2577060A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
DE602005008633D1 (de) * 2004-10-12 2008-09-11 Hoffmann La Roche Imidazoä1,5aütriazoloä1,5dübenzodiazepin-derivative zur behandlung kognitiver störungen
JP4783375B2 (ja) 2004-10-20 2011-09-28 エフ.ホフマン−ラ ロシュ アーゲー イミダゾベンゾジゼピン誘導体
MX2007004640A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de benzodiazepina sustituidos con halogeno.
ES2307230T3 (es) * 2004-12-14 2008-11-16 F. Hoffmann-La Roche Ag Imidazo-benzodiacepinas tetraciclicas como moduladores de los receptores gaba.
EP2682481A3 (en) * 2005-08-03 2014-09-17 The Johns-Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
ATE477255T1 (de) * 2005-10-11 2010-08-15 Hoffmann La Roche Imidazobenzdiazepinderivate
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
PL2358714T3 (pl) * 2008-11-18 2012-12-31 Hoffmann La Roche Etery alkilocykloheksylowe dihydrotetraazabenzoazulenu
SG171846A1 (en) * 2008-11-28 2011-07-28 Hoffmann La Roche Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
DK3034079T3 (en) 2010-11-15 2018-02-05 Agenebio Inc PYRIDAZINE DERIVATIVES, COMPOSITIONS AND PROCEDURES FOR TREATING COGNITIVE WEAKNESS
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
JP2015529254A (ja) * 2012-09-21 2015-10-05 ユーダブリューエム・リサーチ・ファウンデーション,インコーポレーテッド 喘息における気道の過敏症及び炎症を制御するための新規なgabaaアゴニスト及び使用方法
CN112409363B (zh) * 2013-12-20 2023-11-14 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
WO2016205739A1 (en) 2015-06-19 2016-12-22 Belew Mekonnen Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
BR112020026062B1 (pt) * 2018-06-19 2023-04-04 Agenebio, Inc Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
US20240132513A1 (en) 2022-08-19 2024-04-25 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (enExample) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
PL362925A1 (en) 2004-11-02
KR100504300B1 (ko) 2005-07-28
HK1062442A1 (en) 2004-11-05
KR20030045192A (ko) 2003-06-09
ATE268776T1 (de) 2004-06-15
BR0115393A (pt) 2004-07-06
TWI239333B (en) 2005-09-11
US20020103371A1 (en) 2002-08-01
CZ295256B6 (cs) 2005-06-15
WO2002040487A2 (en) 2002-05-23
CN1191255C (zh) 2005-03-02
US6743789B2 (en) 2004-06-01
MXPA03004251A (es) 2003-09-22
PA8532401A1 (es) 2002-08-26
NO20032208L (no) 2003-05-15
AU2002217007B2 (en) 2006-11-30
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
YU35603A (sh) 2006-05-25
MA26962A1 (fr) 2004-12-20
ES2220831T3 (es) 2004-12-16
CN1474820A (zh) 2004-02-11
HRP20030360A2 (en) 2005-04-30
MY141675A (en) 2010-06-15
NO20032208D0 (no) 2003-05-15
UY27026A1 (es) 2002-06-20
SI1337535T1 (en) 2004-10-31
AU1700702A (en) 2002-05-27
GC0000375A (en) 2007-03-31
BG107817A (bg) 2004-07-30
AR031345A1 (es) 2003-09-17
JP2004517070A (ja) 2004-06-10
JP4088151B2 (ja) 2008-05-21
GT200100230A (es) 2002-07-04
CZ20031597A3 (cs) 2003-11-12
EP1337535B1 (en) 2004-06-09
DE60103776D1 (de) 2004-07-15
JO2359B1 (en) 2006-12-12
WO2002040487A3 (en) 2002-09-26
HUP0303281A3 (en) 2005-05-30
EP1337535A2 (en) 2003-08-27
IL155813A0 (en) 2003-12-23
ZA200303435B (en) 2004-08-05
HUP0303281A2 (hu) 2004-01-28
PE20020583A1 (es) 2002-07-06
NO324706B1 (no) 2007-12-03
DE60103776T2 (de) 2005-07-14
ECSP034607A (es) 2003-06-25
SK7232003A3 (en) 2004-03-02
PT1337535E (pt) 2004-09-30
RU2278865C2 (ru) 2006-06-27
CA2427576A1 (en) 2002-05-23
CA2427576C (en) 2007-11-06
RU2003116895A (ru) 2005-02-20

Similar Documents

Publication Publication Date Title
NO20032208L (no) Benzodiazepinderivater som GABA A reseptormodulatorer
DK1284974T3 (da) Triazolyltropanderivater som CCR5-modulatorer
DE60110391D1 (de) Adenosin-rezeptor modulatoren
AU2003290778A8 (en) Non-steroidal farnesoid x receptor modulators
DE50007817D1 (de) Mikrospiegel
DK1444215T3 (da) 1,2,4-Thiadiazoliumderivater som melanocortinreceptormodulatorer
DK1224175T3 (da) Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister
DE60125018D1 (de) Optischer druckaufnehmer
NO20002585L (no) Fremgangsmåte for komplettering av en brönn
NO20032834D0 (no) Benzimidazol- og pyridylimidazol-derivater som ligander for GABA-reseptorer
NO20051042L (no) Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
NO20003730D0 (no) Triazolo-pyridazinderivater som ligander for GABA reseptorer
DE60133250D1 (de) Optischer Modulator
DE60104910D1 (de) Druckeinrichtung
DK1165547T3 (da) Substituerede benzoylpyrazoler som herbicider
NO20000822D0 (no) Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander
DK1263734T3 (da) 3-thiomethylpyrazoler som pesticider
DK1467998T3 (da) Tetracykliske hetaroforbindelser som östrogenreceptormodulatorer
NO20006279L (no) Innretning for generering av en fotonantalltilstand
PT1259535E (pt) Derivados de hexapeptideo ciclico
ES1049394Y (es) Dispositivo para la fijacion de una lampara
EP1377281A4 (en) Taurine compounds
PT1175576E (pt) Acessorio de entrada para um autoclismo
NO20015378L (no) Cyklokarbamatderivater som progesteronreseptormodulatorer
NO20032415L (no) Forbindelser som er aktive på glukokortikoidreseptor II